The Home of the Life Sciences Industry

Pictured: Scales of justice swing in the air/court

Scorpion Stings Harmony with Citizen’s Petition Threat for Sleepiness Drug

Citing reports of “alarming toxicity” among other accusations, short-seller Scorpion Capital will file a Citizen’s Petition with the FDA to have its approval of Wakix withdrawn.
Pictured: Person sitting on the floor, indicating

Positive Phase III Builds Case for Intra-Cellular's Depression Drug

Intra-Cellular Therapies’ Caplyta met its primary endpoint in the Phase III Study 403 trial, easing the burden of depressive episodes in patients with major depressive disorder or bipolar depression.